INS and Alzheimer disease: In conclusion, our data support the view that there is a putative relationship between S100B and metabolic disturbances in AD-like pathology and that the S100B protein acts probably as a cytoprotective factor and may protect neurons against the toxicity of local high levels of glucose or insulin during the initial phases of the pathophysiology of AD.